FDA‘s March 2026 draft guidance on responding to Form 483 observations after drug CGMP inspections is worth reading closely. Not because it creates a new legally enforceable requirement. It does not. It matters because it…
FDA’s new pilot for one day inspectional assessments is worth understanding clearly, because the actual results are more instructive than the headlines suggest. Here is what FDA reported as of late April 2026. The agency…
FDA‘s March 2026 draft guidance on responding to Form 483 observations after drug CGMP inspections is worth reading closely. Not because it creates a new legally enforceable requirement. It does not. It matters because it…
Here Is What the Results Show FDA’s new pilot for one day inspectional assessments is worth understanding clearly, because the actual results are more instructive than the headlines suggest. Here is what FDA reported as…
Embracing Continuous Improvement Continuous improvement is essential for staying ahead in the fast-paced pharmaceutical industry. Continuous improvement involves identifying opportunities for improvement, implementing changes, and measuring the impact of those changes to drive ongoing improvement…
Ensuring Supply Chain Integrity and Security How secure is your Supply Chain? Maintaining supply chain integrity and security is critical for ensuring the quality and safety of pharmaceutical products. The pharmaceutical supply chain is complex…
Establishing Quality Metrics and Key Performance Indicators (KPIs) Establishing quality metrics and key performance indicators (KPIs) is essential for monitoring and improving pharmaceutical quality assurance processes. Quality metrics and KPIs provide valuable insights into the…
Investing In Training and Development Investing in personnel training and development is crucial for maintaining a culture of quality and compliance within your organization. Proper training ensures that employees have the knowledge, skills, and competencies…
Performing Regular Audits and Inspections This post discusses auditing by a drug firm of its internal operations and of its suppliers and contract partners. It does not discuss FDA audits or audits by third-parties. Auditing…
Focusing on Data Integrity Data Integrity (DI) is critical for maintaining the reliability, accuracy, and completeness of data throughout the pharmaceutical lifecycle. In an increasingly digital environment, ensuring data integrity is essential for compliance with…